ARCHIVES

Cyramza-Docetaxel Combination Extends OS In Second-Line NSCLC

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Sends Letter To Grantees To Explain Tighter Funding.

March 16, 2001

NCI Get Go-Ahead For New Cancer Control Projects Totaling $7.4 Million, Funded By Grants, Contracts

October 21, 1977

DCT Advisors Approve Grants Program For Trials Of BRMs

March 10, 1995

Paul Marks To Retire As President, CEO Of Memorial Sloan-Kettering Cancer Center

December 11, 1998

Conversation with The Cancer Letter: Pat White: NIH Funding “Our Only Concern”

September 26, 2014

Senate Subcommittee Gives NCI 41.397 Billion for FY ‘87

August 8, 1986